Chronic Myeloid Leukemia, Chronic Phase
Oncology·MeSH: Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Prevalence
12.0 / 100K
Incidence
1.9 / 100K/yr
0 drugs in development·0 companies·2 clinical trials
Frequently asked questions
How many clinical trials target Chronic Myeloid Leukemia, Chronic Phase?
There are 2 clinical trials targeting Chronic Myeloid Leukemia, Chronic Phase tracked by BioSniper.
What is the prevalence of Chronic Myeloid Leukemia, Chronic Phase?
The estimated prevalence of Chronic Myeloid Leukemia, Chronic Phase is approximately 12.0 per 100,000 population.
Deep-dive into Chronic Myeloid Leukemia, Chronic Phase
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis